TrialBlood2020

Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.

Peter M Voorhees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.